Summit Therapeutics Announces U.K. Court Approval of Scheme
Summit Therapeutics plc (“Summit” or the “Company”) Summit Therapeutics Announces U.K. Court Approval of Scheme; Expects to Complete Redomiciliation to Delaware, USA as of September 18, 2020. Oxford, UK, and Cambridge, MA, US, September 17, 2020 – Summit …